期刊文献+

和肽素在非ST段抬高急性冠脉综合征诊断中的应用研究 被引量:2

Analysis on the Application of the Copeptin in the Diagnosis of Non-ST Segment Elevation Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨和肽素(Copeptin)在非ST段抬高急性冠脉综合征诊断中的应用研究。方法收集在上海市浦东医院心内科收治发病4 h内的非ST段抬高急性冠脉综合征患者120例(观察组),随机选取40例冠脉造影无异常患者为对照组。检测患者发病后4 h、12 h和24 h的血浆Copeptin及超敏肌钙蛋白I(cTnI),并与对照组比较。通过ROC曲线评估Copeptin的最佳诊断点,计算敏感性及特异性。结果在发病后4 h、12 h和24 h中,患者血浆Copeptin和cTnI水平明显高于对照组,差异有统计学意义(P<0.05)。对NSTE-ACS组不同时间段血浆Copeptin和cTnI水平进行组内比较,差异有统计学意义(F分别=5.87、12.36,P均<0.05)。通过ROC曲线,Copeptin的最大曲线下面积(AUC)为0.739,最佳诊断点为11.03 pmol/L,此时诊断NSTE-ACS的敏感性为90.0%,特异性为67.5%。而cTnI以0.05 ng/ml为诊断临界点,诊断NSTE-ACS的敏感性为51.9%,特异性为95.0%。结论和肽素对非ST段抬高急性冠脉综合征的诊断敏感性优于超敏肌钙蛋白I,具有较好的诊断价值,值得临床应用。 OBJECTIVE To observe the application of the Copeptin in the diagnosis of non-ST segment elevation acute coronary syndrome.METHODS 120 patients with suspected non-ST segment elevation acute coronary syndrome within 4 hours of onset(named the Observer Group) were collected in hospital Cardiology,then randomly selected 40 healthy patients as a control group.The serum copeptin and sensitive troponin I were detected respectively after onset 4h,12 h,24h,and compared with the control group.Assessment the best diagnostic point of the Copeptin by the ROC curve,and calculate the sensitivity and specificity.RESULT After onset4 h,12h,24 h,the serum copeptin and sensitive troponin I significantly higher than the control group,the difference was statistically significant(P〈0.05).The plasma Copeptin and cTnI levels were compared within the NSTE-ACS group for different time periods,the difference was statistically significant(F respectively=5.87,12.36,P〈0.05).Through ROC curve,the largest area under the curve(AUC) of Copeptin was 0.739,and the best diagnostic point of 11.03pmol/L,at this point,the diagnostic sensitivity of NSTE-ACS was90.0%and specificity of 67.5%.cTnI was 0.05 ng/ml as the diagnosis of the critical point,the diagnostic sensitivity of NSTE-ACS was 51.9%,specificity of 95.0%.CONCLUSION The diagnostic sensitivity of Copeptin in non-ST segment elevation acute coronary syndrome was superior to sensitive troponin I,with a good diagnostic value,which was worthy of clinical application.
出处 《中国初级卫生保健》 2015年第12期110-111,114,共3页 Chinese Primary Health Care
基金 上海市浦东新区科委课题(PJK 2014-Y25)
关键词 和肽素 非ST段抬高急性冠脉综合征 超敏肌钙蛋白I Copeptin Non-ST segment elevation acute coronary syndrome Sensitive troponin Ⅰ
  • 相关文献

参考文献16

二级参考文献76

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 3Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiolagy/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction ). J Am Coll Cardiol,1999,34:890-911.
  • 4Janczak J, Krupienicz A, Roszczyk E, et al. PRIMARY CORONARY ANGIOPLASTY versus THROMBOLYTIC THERAPY. Comparison of mortality in the acute phase of myocardial infarction - a single centre experience. Kardiol Pol, 2002,57:542-550.
  • 5Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevatian myocardial infarction: a report of the American College of Cardiolagy/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation ,2004,110 : e82-292.
  • 6Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet,2001,357 : 1385-1390.
  • 7ISIS-4 ( Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral monanitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet,1995, 345,669 -685.
  • 8Collins R, Peto R, Baigent C, et al. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med, 1997,336:847-860.
  • 9Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 10Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.

共引文献3105

同被引文献30

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部